Abstract:The constant and the sudden emergence of zoonotic human and animal viruses is a significant threat to human health, the world economy, and the world food supply. This has necessitated the development of broad-spectrum therapeutic strategies to combat these emerging pathogens. Mechanisms that are essential for viral replication and propagation have been successfully targeted in the past to develop broad-spectrum therapeutics that can be readily repurposed to combat new zoonotic pathogens. Because of the importance of viral RNA capping enzymes to viral replication and pathogenesis, as well as their presence in both DNA and RNA viruses, these viral proteins have been a long-standing therapeutic target. Here, we use genome sequencing information and yeast-based platforms (YeRC0M) to identify, characterize, and target viral genome-encoded essential RNA capping enzymes from emerging strains of DNA viruses, i.e., Monkeypox virus and African Swine Fever Virus, which are a significant threat to human and domestic animal health. We first identified and biochemically characterized these viral RNA capping enzymes and their necessary protein domains. We observed significant differences in functional protein domains and organization for RNA capping enzymes from emerging DNA viruses in comparison to emerging RNA viruses. We also observed several differences in the biochemical properties of these viral RNA capping enzymes using our phenotypic yeast-based approaches (YeRC0M) as compared to the previous in vitro studies. Further, using directed evolution, we were able to identify inactivation and attenuation mutations in these essential viral RNA capping enzymes; these data could have implications on virus biocontainment as well as live attenuated vaccine development. We also developed methods that would facilitate high-throughput phenotypic screening to identify broad-spectrum inhibitors that selectively target viral RNA capping enzymes over host RNA capping enzymes. As demonstrated here, our approaches to identify, characterize, and target viral genome-encoded essential RNA capping enzymes are highly modular and can be readily adapted for targeting emerging viral pathogens as well as their variants that emerge in the future.

High-efficiency genetic engineering toolkit for virus based on lambda red-mediated recombination

Virus engineering: Fighting HIV at its own game.

Rational design of self-amplifying virus-like vesicles with Ebola virus glycoprotein as vaccines

HHi-FiVe: A high-fidelity genetic engineering pipeline for construction of herpesvirus-based vaccines

Efficient rescue of a newly classified Ebinur lake orthobunyavirus with GFP reporter and its application in rapid antiviral screening

An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening

Construction and Evaluation of DNA Vaccine Encoding Ebola Virus Glycoprotein Fused with Lysosome-Associated Membrane Protein

Ebola Virus Entry: From Molecular Characterization to Drug Discovery

Directed evolution of engineered virus-like particles with improved production and transduction efficiencies

Exploiting the Reverse Vaccinology Approach to Design Novel Subunit Vaccine against Ebola Virus

Computational Models for Trapping Ebola Virus Using Engineered Bacteria

Lentiviral Delivery of Proteins for Genome Engineering

Single-cell image-based genetic screens systematically identify regulators of Ebola virus subcellular infection dynamics

[A rapid and accurate method for herpesviral gnome editing]

Characterization, Directed Evolution, and Targeting of DNA Virus-Encoded RNA Capping Enzymes Using Phenotypic Yeast Platforms

Optimization of PCA Error Correction Conditions to Improve Efficiency of Virus Genome De Novo Synthesis

Recombinant Lloviu virus as a tool to study viral replication and host responses

Red recombination enables a wide variety of markerless manipulation of porcine epidemic diarrhea virus genome to generate recombinant virus

Molecular Engineering of Virus Tropism

An efficient method for knocking out genes on the virulence plasmid of hypervirulent <i>Klebsiella pneumoniae</i>

Vaccinia-based Vaccines to Biothreat and Emerging Viruses